Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
Guido Giordano, Massimo Pancione, Nunzio Olivieri, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 32, pp. 5875-5875
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 294
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
Duxin Sun, Simon Zhou, Wei Gao
ACS Nano (2020) Vol. 14, Iss. 10, pp. 12281-12290
Open Access | Times Cited: 202
Role of the tumor microenvironment in pancreatic cancer
Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, et al.
Annals of Gastroenterological Surgery (2019) Vol. 3, Iss. 2, pp. 130-137
Open Access | Times Cited: 147
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 82
New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 71
Challenges and Opportunities in the Delivery of Cancer Therapeutics: Update on Recent Progress
Mathilde Lorscheider, Alice Gaudin, Jessica Nakhlé, et al.
Therapeutic Delivery (2020) Vol. 12, Iss. 1, pp. 55-76
Closed Access | Times Cited: 81
Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
Jay Z. Natu, Ganji Purnachandra Nagaraju
Cancer Letters (2023) Vol. 573, pp. 216382-216382
Open Access | Times Cited: 34
miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2
Zhengliang Zhang, Xiangming Che, Ni Yang, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 96, pp. 1341-1348
Closed Access | Times Cited: 81
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L. Miller, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1627-1627
Open Access | Times Cited: 73
Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation
Xin Luan, Hebao Yuan, Yudong Song, et al.
Biomaterials (2021) Vol. 275, pp. 120910-120910
Open Access | Times Cited: 51
When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications
Kazuaki Taguchi, Yuko Okamoto, Kazuaki Matsumoto, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 296-296
Open Access | Times Cited: 43
The nanoparticle-Protein Corona untold history (1907–2007)
Eudald Casals, Michele Vitali, Víctor Puntes
Nano Today (2024) Vol. 58, pp. 102435-102435
Closed Access | Times Cited: 6
Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer
Epiphane K. Silli, Mengfei Li, Yuting Shao, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 13-24
Closed Access | Times Cited: 15
Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells
Jianwen Zhou, Mingshuang Sun, Shanshan Jin, et al.
Drug Delivery (2019) Vol. 26, Iss. 1, pp. 281-289
Open Access | Times Cited: 41
The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic Cancer
Si Shi, Chen Liang, Jin Xu, et al.
Annals of Surgery (2018) Vol. 271, Iss. 3, pp. 559-565
Closed Access | Times Cited: 40
Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
Rujing Chen, Leaf Huang, Kaili Hu
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2140-2155
Open Access | Times Cited: 39
Nano drug delivery systems in upper gastrointestinal cancer therapy
Julia Salapa, Allison Bushman, Kevin Lowe, et al.
Nano Convergence (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 37
Polymer nanoparticle-assisted chemotherapy of pancreatic cancer
Tianqi Su, Bo Yang, Tianren Gao, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 35
Advancements in Nanotechnology for Targeted and Controlled Drug Delivery in Hematologic Malignancies: Shaping the Future of Targeted Therapeutics
Abdurraouf Mokhtar Mahmoud, Clara Deambrogi
Applied Biosciences (2025) Vol. 4, Iss. 1, pp. 16-16
Open Access
Polyallylamine Hydrochloride-Modified Bovine Serum Albumin Nanoparticles Loaded with α-Solanine for Chemotherapy of Pancreatic Cancer
Zhengde Wen, Shan Luo, Juntao Liu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4235-4255
Open Access
Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model
Diane Bressand, Anthony Novell, Alban Girault, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 9, pp. 3814-3822
Open Access | Times Cited: 35
Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
Paola Parente, Pietro Parcesepe, Claudia Covelli, et al.
Gastroenterology Research and Practice (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 33
Clinical Application of Nano-Targeting for Enhancing Chemotherapeutic Efficacy and Safety in Cancer Management
Matthew Phillips, Shaker A. Mousa
Nanomedicine (2022) Vol. 17, Iss. 6, pp. 405-421
Closed Access | Times Cited: 17
αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment
Prashant Kesharwani, Jyoti Chandra, Shahid Karim, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105663-105663
Closed Access | Times Cited: 3
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
Johannes Betge, Jing Chi-Kern, Nadine Schulte, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top